Down Syndrome Diagnosis: Sequenom Moves Closer To Noninvasive Test
This article was originally published in The Gray Sheet
Executive Summary
Sequenom has made progress towards being first-to-market with a blood test to replace invasive prenatal Down syndrome diagnostics despite a challenge along the way from an upstart group out of Stanford University